Insiders · NBIX

Eric Benevich

Chief Commercial Officer at Neurocrine Biosciences Inc (NBIX)

Eric Benevich has filed 36 insider reports with the SEC since January 2021, as chief Commercial Officer at Neurocrine Biosciences Inc (NBIX) and director at aTYR PHARMA INC (ATYR). In the last 12 months Eric Benevich sold $333K of stock on the open market. The latest filing, on September 15, 2026, reports grant or award and shares withheld for taxes or exercise price at Neurocrine Biosciences Inc (NBIX).

Filings
36
Companies
2
Bought on market
None
Sold on market
$39.9M

Companies where Eric Benevich is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Neurocrine Biosciences Inc logo
NBIX
Neurocrine Biosciences Inc
Chief Commercial Officer67,297$39.9M$162.86Sep 15, 2026
aTYR PHARMA INC logo
ATYR
aTYR PHARMA INC
Directorsince December 2024$4.08May 13, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Eric Benevich with

Other insiders at the same companies

Questions about Eric Benevich

What is Eric Benevich's role at Neurocrine Biosciences Inc?
Eric Benevich reports to the SEC as chief Commercial Officer at Neurocrine Biosciences Inc (NBIX), according to the latest filing on September 15, 2026. Eric Benevich has also filed as director at aTYR PHARMA INC (ATYR).
How many shares does Eric Benevich own?
After the latest filing that states it, Eric Benevich directly owned 67,297 shares of Neurocrine Biosciences Inc (NBIX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Eric Benevich bought or sold stock recently?
The most recent open-market sale was on September 9, 2026: sold 2,154 shares of Neurocrine Biosciences Inc (NBIX) for $333K at an average of $154.61.
How do I get alerts when Eric Benevich files?
Follow Eric Benevich on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Eric Benevich filed 2 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by Eric Benevich (SEC CIK 0001643653). Totals count each trade once, skipping amendments whose original is on file, from Jan 28, 2021 on. View on SEC EDGAR